Literature DB >> 19661445

Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats.

Jae Hyung Kim1, Lukasz J Bugaj, Young Jun Oh, Trinity J Bivalacqua, Sungwoo Ryoo, Kevin G Soucy, Lakshmi Santhanam, Alanah Webb, Andre Camara, Gautam Sikka, Daniel Nyhan, Artin A Shoukas, Monica Ilies, David W Christianson, Hunter C Champion, Dan E Berkowitz.   

Abstract

There is increasing evidence that upregulation of arginase contributes to impaired endothelial function in aging. In this study, we demonstrate that arginase upregulation leads to endothelial nitric oxide synthase (eNOS) uncoupling and that in vivo chronic inhibition of arginase restores nitroso-redox balance, improves endothelial function, and increases vascular compliance in old rats. Arginase activity in old rats was significantly increased compared with that shown in young rats. Old rats had significantly lower nitric oxide (NO) and higher superoxide (O2(-)) production than young. Acute inhibition of both NOS, with N(G)-nitro-l-arginine methyl ester, and arginase, with 2S-amino- 6-boronohexanoic acid (ABH), significantly reduced O2(-) production in old rats but not in young. In addition, the ratio of eNOS dimer to monomer in old rats was significantly decreased compared with that shown in young rats. These results suggest that eNOS was uncoupled in old rats. Although the expression of arginase 1 and eNOS was similar in young and old rats, inducible NOS (iNOS) was significantly upregulated. Furthermore, S-nitrosylation of arginase 1 was significantly elevated in old rats. These findings support our previously published finding that iNOS nitrosylates and activates arginase 1 (Santhanam et al., Circ Res 101: 692-702, 2007). Chronic arginase inhibition in old rats preserved eNOS dimer-to-monomer ratio and significantly reduced O2(-) production and enhanced endothelial-dependent vasorelaxation to ACh. In addition, ABH significantly reduced vascular stiffness in old rats. These data indicate that iNOS-dependent S-nitrosylation of arginase 1 and the increase in arginase activity lead to eNOS uncoupling, contributing to the nitroso-redox imbalance, endothelial dysfunction, and vascular stiffness observed in vascular aging. We suggest that arginase is a viable target for therapy in age-dependent vascular stiffness.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19661445      PMCID: PMC2763842          DOI: 10.1152/japplphysiol.91393.2008

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  58 in total

1.  Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age.

Authors:  S Meaume; A Benetos; O F Henry; A Rudnichi; M E Safar
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-12       Impact factor: 8.311

Review 2.  Ageing of the conduit arteries.

Authors:  S E Greenwald
Journal:  J Pathol       Date:  2007-01       Impact factor: 7.996

3.  Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2.

Authors:  Sangwon F Kim; Daniel A Huri; Solomon H Snyder
Journal:  Science       Date:  2005-12-23       Impact factor: 47.728

4.  Alterations of nitric oxide synthase expression with aging and hypertension in rats.

Authors:  T C Chou; M H Yen; C Y Li; Y A Ding
Journal:  Hypertension       Date:  1998-02       Impact factor: 10.190

5.  Impaired shear stress-induced nitric oxide production through decreased NOS phosphorylation contributes to age-related vascular stiffness.

Authors:  Kevin G Soucy; Sungwoo Ryoo; Alexandre Benjo; Hyun Kyo Lim; Gaurav Gupta; Jayson S Sohi; Jeremy Elser; Miguel A Aon; Daniel Nyhan; Artin A Shoukas; Dan E Berkowitz
Journal:  J Appl Physiol (1985)       Date:  2006-12

Review 6.  Role of oxidative and nitrosative stress, longevity genes and poly(ADP-ribose) polymerase in cardiovascular dysfunction associated with aging.

Authors:  Anna Csiszar; Pal Pacher; Gabor Kaley; Zoltan Ungvari
Journal:  Curr Vasc Pharmacol       Date:  2005-07       Impact factor: 2.719

7.  Development of progressive aortic vasculopathy in a rat model of aging.

Authors:  Steven J Miller; William C Watson; Kimberly A Kerr; Carlos A Labarrere; Neal X Chen; Mark A Deeg; Joseph L Unthank
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-09-14       Impact factor: 4.733

8.  Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells.

Authors:  Louis G Chicoine; Michael L Paffett; Tamara L Young; Leif D Nelin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-02-20       Impact factor: 5.464

9.  Arginase and autoimmune inflammation in the central nervous system.

Authors:  Lingyun Xu; Brendan Hilliard; Ruaidhrí J Carmody; Galit Tsabary; Hyunshun Shin; David W Christianson; Youhai H Chen
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397

10.  Endothelial arginase II: a novel target for the treatment of atherosclerosis.

Authors:  Sungwoo Ryoo; Gaurav Gupta; Alexandre Benjo; Hyun Kyo Lim; Andre Camara; Gautam Sikka; Hyun Kyung Lim; Jayson Sohi; Lakshmi Santhanam; Kevin Soucy; Eric Tuday; Ezra Baraban; Monica Ilies; Gary Gerstenblith; Daniel Nyhan; Artin Shoukas; David W Christianson; Nicholas J Alp; Hunter C Champion; David Huso; Dan E Berkowitz
Journal:  Circ Res       Date:  2008-02-28       Impact factor: 17.367

View more
  98 in total

1.  Upregulation of arginase-II contributes to decreased age-related myocardial contractile reserve.

Authors:  Mehnaz Khan; Jochen Steppan; Karl H Schuleri; Karl Schuleri; Sungwoo Ryoo; Eric Tuday; Lukasz Bugaj; Lakshmi Santhanam; Tal Berkowitz; Daniel Nyhan; Artin A Shoukas; Dan E Berkowitz
Journal:  Eur J Appl Physiol       Date:  2011-12-08       Impact factor: 3.078

2.  Superoxide-lowering therapy with TEMPOL reverses arterial dysfunction with aging in mice.

Authors:  Bradley S Fleenor; Douglas R Seals; Melanie L Zigler; Amy L Sindler
Journal:  Aging Cell       Date:  2012-01-19       Impact factor: 9.304

3.  Upregulation of inducible nitric oxide synthase contributes to attenuated cutaneous vasodilation in essential hypertensive humans.

Authors:  Caroline J Smith; Lakshmi Santhanam; Rebecca S Bruning; Anna Stanhewicz; Dan E Berkowitz; Lacy A Holowatz
Journal:  Hypertension       Date:  2011-09-19       Impact factor: 10.190

4.  Nitrite supplementation reverses vascular endothelial dysfunction and large elastic artery stiffness with aging.

Authors:  Amy L Sindler; Bradley S Fleenor; John W Calvert; Kurt D Marshall; Melanie L Zigler; David J Lefer; Douglas R Seals
Journal:  Aging Cell       Date:  2011-03-31       Impact factor: 9.304

5.  Enteral arginase II provides ornithine for citrulline synthesis.

Authors:  Juan C Marini; Bettina Keller; Inka Cajo Didelija; Leticia Castillo; Brendan Lee
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-10-26       Impact factor: 4.310

6.  Arginase II inhibition prevents nitrate tolerance.

Authors:  S M L Khong; K L Andrews; N N Huynh; K Venardos; A Aprico; D L Michell; M Zarei; K T Moe; G J Dusting; D M Kaye; J P F Chin-Dusting
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

7.  Hyperglycemia-impaired aortic vasorelaxation mediated through arginase elevation: Role of stress kinase pathways.

Authors:  Surabhi Chandra; David J R Fulton; Ruth B Caldwell; R William Caldwell; Haroldo A Toque
Journal:  Eur J Pharmacol       Date:  2018-11-28       Impact factor: 4.432

8.  Impaired activity of adherens junctions contributes to endothelial dilator dysfunction in ageing rat arteries.

Authors:  Fumin Chang; Sheila Flavahan; Nicholas A Flavahan
Journal:  J Physiol       Date:  2017-06-30       Impact factor: 5.182

9.  Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout.

Authors:  Lin Yao; Surabhi Chandra; Haroldo A Toque; Anil Bhatta; Modesto Rojas; Ruth B Caldwell; R William Caldwell
Journal:  Cardiovasc Res       Date:  2012-12-17       Impact factor: 10.787

Review 10.  Redox signaling in cardiovascular health and disease.

Authors:  Nageswara R Madamanchi; Marschall S Runge
Journal:  Free Radic Biol Med       Date:  2013-04-11       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.